» Articles » PMID: 20819076

Interaction with Receptor for Activated C-kinase 1 (RACK1) Sensitizes the Phosphodiesterase PDE4D5 Towards Hydrolysis of CAMP and Activation by Protein Kinase C

Overview
Journal Biochem J
Specialty Biochemistry
Date 2010 Sep 8
PMID 20819076
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

We have previously identified the PKC (protein kinase C)-anchoring protein RACK1 (receptor for activated C-kinase 1), as a specific binding partner for the cAMP-specific phosphodiesterase PDE4D5, suggesting a potential site for cross-talk between the PKC and cAMP signalling pathways. In the present study we found that elevation of intracellular cAMP, with the β₂-adrenoceptor agonist isoproterenol (isoprenaline), led to activation of PDE4 enzymes in the particulate and soluble fractions of HEK (human embryonic kidney)-293 cells. In contrast activation of PDE4D5, with isoproterenol and the PKC activator PMA, was restricted to the particulate fraction, where it interacts with RACK1; however, RACK1 is dispensable for anchoring PDE4D5 to the particulate fraction. Kinetic studies demonstrated that RACK1 alters the conformation of particulate-associated PDE4D5 so that it more readily interacts with its substrate cAMP and with rolipram, a PDE4 inhibitor that specifically targets the active site of the enzyme. Interaction with RACK1 was also essential for PKC-dependent and ERK (extracellular-signal-regulated kinase)-independent phosphorylation (on Ser¹²⁶), and activation of PDE4D5 in response to PMA and isoproterenol, both of which trigger the recruitment of PKCα to RACK1. Together these results reveal novel signalling cross-talk, whereby RACK1 mediates PKC-dependent activation of PDE4D5 in the particulate fraction of HEK-293 cells in response to elevations in intracellular cAMP.

Citing Articles

PDE4D: A Multipurpose Pharmacological Target.

Lusardi M, Rapetti F, Spallarossa A, Brullo C Int J Mol Sci. 2024; 25(15).

PMID: 39125619 PMC: 11311937. DOI: 10.3390/ijms25158052.


Identification of RACK1 as a novel regulator of non-structural protein 4 of chikungunya virus.

Yan Y, Zhang F, Zou M, Chen H, Xu J, Lu S Acta Biochim Biophys Sin (Shanghai). 2024; 56(10):1425-1436.

PMID: 38813597 PMC: 11532265. DOI: 10.3724/abbs.2024073.


RACK1 interaction with c-Src is essential for osteoclast function.

Park J, Jeong E, Lin J, Ko R, Kim J, Yi S Exp Mol Med. 2019; 51(7):1-9.

PMID: 31358728 PMC: 6802652. DOI: 10.1038/s12276-019-0285-4.


Transcriptomic analysis of Sf9 cells resistant to Cry1Ca toxin reveals that extracellular Ca, Mg and production of cAMP are involved in toxicity.

Castella C, Pauron D, Hilliou F, Trang V, Zucchini-Pascal N, Gallet A Biol Open. 2019; 8(4).

PMID: 30926594 PMC: 6503997. DOI: 10.1242/bio.037085.


The interaction between RACK1 and WEE1 regulates the growth of gastric cancer cell line HGC27.

Liu C, Ren L, Wang Y, Liu Y, Xiao J Oncol Lett. 2017; 14(4):4784-4792.

PMID: 29085480 PMC: 5649583. DOI: 10.3892/ol.2017.6741.


References
1.
Shabb J . Physiological substrates of cAMP-dependent protein kinase. Chem Rev. 2001; 101(8):2381-411. DOI: 10.1021/cr000236l. View

2.
Blumberg P . Protein kinase C as the receptor for the phorbol ester tumor promoters: sixth Rhoads memorial award lecture. Cancer Res. 1988; 48(1):1-8. View

3.
Kramer A, Schneider-Mergener J . Synthesis and screening of peptide libraries on continuous cellulose membrane supports. Methods Mol Biol. 1998; 87:25-39. DOI: 10.1385/0-89603-392-9:25. View

4.
Frank R . The SPOT-synthesis technique. Synthetic peptide arrays on membrane supports--principles and applications. J Immunol Methods. 2002; 267(1):13-26. DOI: 10.1016/s0022-1759(02)00137-0. View

5.
Conti M, Richter W, Mehats C, Livera G, Park J, Jin C . Cyclic AMP-specific PDE4 phosphodiesterases as critical components of cyclic AMP signaling. J Biol Chem. 2002; 278(8):5493-6. DOI: 10.1074/jbc.R200029200. View